These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 645717)

  • 21. Drug information for patients--an update of long-term results: type of enquiries and patient characteristics.
    Huber M; Kullak-Ublick GA; Kirch W
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):111-9. PubMed ID: 19101916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Norwegian cancer hospitals web sites and explorative survey among cancer patients on their use of the internet.
    Norum J
    J Med Internet Res; 2001; 3(4):E30. PubMed ID: 11772545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External quality assurance committee for drug information services.
    Smith CJ; Sylvia LM
    Am J Hosp Pharm; 1990 Apr; 47(4):787-91. PubMed ID: 2321653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug information center--at your service.
    Hosp Formul; 1978 Aug; 13(8):607. PubMed ID: 10308295
    [No Abstract]   [Full Text] [Related]  

  • 25. A drug information service quality assurance audit.
    Hart LL; Miwa LJ; Millares M
    Hosp Formul; 1989 Jul; 24(7):383-6, 388-9. PubMed ID: 10293845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of implementing and maintaining a hospital-pharmacy-based online literature search system.
    Souney PF; Churchill WW; Kaul AF
    Am J Hosp Pharm; 1985 Nov; 42(11):2496-8. PubMed ID: 4073067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do men with prostate or colorectal cancer seek different information and support from women with cancer?
    Boudioni M; McPherson K; Moynihan C; Melia J; Boulton M; Leydon G; Mossman J
    Br J Cancer; 2001 Sep; 85(5):641-8. PubMed ID: 11531244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical pharmacological drug information. Well over one year's experience].
    Heisterberg J; Christophersen AB; Christensen HR; Sonne J
    Ugeskr Laeger; 1999 Jun; 161(26):4005-7. PubMed ID: 10402937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of pharmacovigilance center in information for the public on drugs. Experience in Marseille on 9 month].
    Jean-Pastor MJ; Morange-Sala S; Rodor F; Gambini D; Galland MC; David JM; Jouglard J
    Therapie; 1992; 47(5):429-32. PubMed ID: 1299984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profile of medication identification requests managed by a U.S.-certified regional poison information center.
    Krenzelok EP; Mrvos R
    Clin Toxicol (Phila); 2009 Apr; 47(4):364-5. PubMed ID: 19365774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The B.C. drug and poison information centre.
    Hlynka JN; Golightly LK; Willis GA
    Can J Hosp Pharm; 1978; 31(4):129-31. PubMed ID: 10237306
    [No Abstract]   [Full Text] [Related]  

  • 32. The Medication Information Line for the Elderly. A consumer/health care professional-oriented drug information service.
    Grymonpré RE; Steele JW; Schultz BR
    CPJ; 1987 May; 120(5):324-6, 327-30. PubMed ID: 10282069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health professionals' use of drug information centers.
    Cardoni AA; Chapron DJ; Dobson DB
    Am J Hosp Pharm; 1978 Dec; 35(12):1476, 1479, 1481. PubMed ID: 717404
    [No Abstract]   [Full Text] [Related]  

  • 34. Strategic planning for clinical services: the University of Texas M.D. Anderson Hospital and Tumor Institute.
    Anderson RW
    Am J Hosp Pharm; 1986 Sep; 43(9):2169-73. PubMed ID: 3532778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug information services for consumers and health professionals.
    Conner CS; Murphrey KJ; Sawyer D; Murakami K; Rumack BH; Ford PS
    Am J Hosp Pharm; 1980 Sep; 37(9):1215-9. PubMed ID: 7416177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ENT expert assessment for federal health insurance in North Rhine. A contribution to the internal discussion of quantitative and qualitative optimization of the expert witness process].
    Lauven G; Buszello HP; Müller-Held W
    Gesundheitswesen; 1999 Apr; 61(4):179-84. PubMed ID: 10408144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Policy and procedure manual. Recording of drug information requests.
    Curr Concepts Hosp Pharm Manage; 1989; 11(1):17-8. PubMed ID: 10291720
    [No Abstract]   [Full Text] [Related]  

  • 38. Information on antineoplastic drugs for nononcologist physicians.
    Ballentine R; Primeaux J
    Am J Hosp Pharm; 1977 Aug; 34(8):839-43. PubMed ID: 900136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional drug information service.
    Schwarz UI; Stoelben S; Ebert U; Siepmann M; Krappweis J; Kirch W
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):263-8. PubMed ID: 10395116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstetric drug information service.
    Arulappu RG; Taylor DJ
    Am J Hosp Pharm; 1982 Sep; 39(9):1511-4. PubMed ID: 7137189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.